Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617.
Wei, Xiao
Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617. [electronic resource] - Clinical nuclear medicine Nov 2016 - 894-895 p. digital
Publication Type: Case Reports; Journal Article
1536-0229
10.1097/RLU.0000000000001358 doi
Aged, 80 and over
Dipeptides--therapeutic use
Heterocyclic Compounds, 1-Ring--therapeutic use
Humans
Liver Neoplasms--diagnostic imaging
Lutetium
Male
Prostate-Specific Antigen
Prostatic Neoplasms, Castration-Resistant--diagnostic imaging
Radiopharmaceuticals--therapeutic use
Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617. [electronic resource] - Clinical nuclear medicine Nov 2016 - 894-895 p. digital
Publication Type: Case Reports; Journal Article
1536-0229
10.1097/RLU.0000000000001358 doi
Aged, 80 and over
Dipeptides--therapeutic use
Heterocyclic Compounds, 1-Ring--therapeutic use
Humans
Liver Neoplasms--diagnostic imaging
Lutetium
Male
Prostate-Specific Antigen
Prostatic Neoplasms, Castration-Resistant--diagnostic imaging
Radiopharmaceuticals--therapeutic use